B r i e f c o m m u n i c at i o n s
The C9orf72 gene contains a polymorphic hexanucleotide repeat, GGGGCC, located in an intron. In people with C9orf72-associated FTD or ALS (c9FTD/ALS), the hexanucleotide repeat tract is expanded to hundreds or even thousands of repeats 1, 2 . A hypothesis has emerged to explain how GGGGCC repeat expansion in C9orf72 could cause disease: repeat-associated non-ATG (RAN) translation. This unconventional form of translation occurs in all reading frames (sense and antisense directions) of the expanded GGGGCC nucleotide repeat, producing polymers of the predicted dipeptides: Gly-Ala, Gly-Pro, Pro-Ala, Gly-Arg and Pro-Arg. These dipeptide repeat proteins (DPRs) are themselves aggregation-prone and accumulate in the CNS of affected C9orf72 mutation carriers [3] [4] [5] . But does pathology equal pathogenesis? In other words, are these DPRs toxic, causing neurodegeneration, or are they merely benign bystanders? If they are toxic, then defining the mechanisms by which they contribute to neurodegeneration will provide strategies for therapeutic intervention.
Several groups recently reported experiments demonstrating that C9orf72 DPRs are toxic and can cause neurodegeneration [5] [6] [7] [8] [9] [10] [11] . The arginine-rich DPRs, Gly-Arg and Pro-Arg, seem to be particularly toxic 6, 7, 11 . The challenge now is to define the cellular pathways affected by the toxic C9orf72 DPRs. We have previously used yeast as a model system to gain insight into other ALS disease proteins, including TDP-43 and FUS [12] [13] [14] . To investigate potential toxicity of C9orf72 DPRs in yeast, we expressed constructs harboring 50 repeats of four of the five different predicted DPRs (Gly-Ala, Gly-Arg, Pro-Ala, ProArg) under the control of a strong inducible promoter, the galactoseinducible promoter. To focus specifically on DPR toxicity and not RNA-related toxicity, we generated codon-optimized constructs to express each DPR independently, without using the GGGGCC repetitive sequence. We transformed these constructs into wild-type yeast cells and assessed the effects on growth using spotting assays. Strikingly consistent with the results in Drosophila and mammalian cells, the arginine-rich DPRs were toxic, with (Pro-Arg) 50 expression leading to the highest toxicity ( Fig. 1a and Supplementary  Fig. 1a ). (Gly-Arg) 50 was less toxic in yeast than (Pro-Arg) 50 ( Fig. 1a,b) . Increasing the number of Gly-Arg repeats to 100 ((Gly-Arg) 100 ) increased toxicity (Fig. 1b) . Thus, this simple yeast model recapitulates arginine-rich C9orf72 DPR toxicity.
To gain insight into the mechanisms of C9orf72 pathogenesis, we used an unbiased genetic approach to identify genes that could suppress or enhance DPR toxicity in yeast. We focused on Pro-Arg because of its robust toxicity and because it elicited toxicity and neurodegeneration in mammalian cells and Drosophila 6, 7, 11 . We performed two complementary genome-wide screens. First, we performed a genome-wide plasmid overexpression screen (Fig. 1c) . We individually transformed 5,500 yeast genes, which comprise the yeast FLEXGene plasmid library, into a yeast strain expressing (Pro-Arg) 50 . We identified genes that either suppressed or enhanced (Pro-Arg) 50 toxicity (that is, allowed the cells to grow better or worse in the presence of (Pro-Arg) 50 expression) (Fig. 1d) . We conducted the screen two independent times and verified any potential hits at least three more times with independent transformations and spotting assays. This screen identified 27 (Pro-Arg) 50 toxicity suppressors and 35 enhancers ( Table 1) . We performed immunocytochemistry and immunoblotting to define the impact of the modifiers on (Pro-Arg) 50 localization and expression levels (see Online Methods and Supplementary Fig. 1b,c) .
Next, to complement the plasmid overexpression screen, we also screened a library of all 4,850 non-essential yeast gene knockouts to identify deletions that could suppress (Pro-Arg) 50 toxicity (Fig. 1e) . Hits from this screen (gene deletions that suppress a phenotype) are of particular interest because they could represent potential drug targets. We identified 16 yeast genes that suppressed (Pro-Arg) 50 toxicity when deleted ( Table 2) . That is, deletions of these genes improved the growth of yeast cells expressing (Pro-Arg) 50 , which is extremely toxic on its own. Some of these deletions seemed to nearly completely Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS B r i e f c o m m u n i c at i o n s suppress (Pro-Arg) 50 toxicity ( Fig. 1f and Supplementary Figs. 1c,d and 2a,b) .
Combining the results from the gain-and loss-of-function screens, we found a striking enrichment in genes functioning in nucleocytoplasmic transport using gene ontology analysis (P = 5.9 × 10 −4 ) (Fig. 1g) . Six of the strongest modifier genes from the plasmid overexpression screen encoded highly conserved members of the karyopherin family of nuclear import proteins (Fig. 1d) . We performed immunocytochemistry to define the impact of the karyopherins on (Pro-Arg) 50 localization. Upregulation of karyopherins rescued toxicity but did not alter localization or levels of the DPRs (Supplementary Fig. 1b,c) . Thus, the upregulation of karyopherins might restore nucleocytoplasmic transport per se, rather than specifically affecting the localization of the DPRs.
We identified yeast MTR10 as a suppressor of (Pro-Arg) 50 toxicity. Mtr10p is an import receptor that mediates the nuclear import of serine:arginine domain-containing (SR) proteins and their bound mRNAs and RNA-binding proteins 15 . It has been proposed that arginine-rich C9orf72 DPRs compete with SR proteins for binding to ribonucleoprotein granules 7 . Our genetic results suggest a possible way to overcome this blockade by upregulating the SR protein import receptor. We also identified KAP104, the yeast homolog of karyopherin β2 (also called transportin 1), which mediates nuclear import of the ALS disease protein FUS (Fig. 1d) . ALS-associated mutations in the FUS nuclear localization signal are known to disrupt karyopherin β2-mediated nuclear import 16 , and disturbances in nuclear import are a pathological feature of FTD cases with FUS pathology (FTD-FUS) 17 .
Because yeast karyopherin genes were among the strongest suppressors of (Pro-Arg) 50 toxicity in our yeast screen when upregulated, it suggests that strategies to boost production or enhance function of karyopherin proteins could be a therapeutic strategy for protecting against C9orf72 DPR proteotoxicity. We performed experiments to rescue (Pro-Arg) 50 toxicity in primary rodent neurons with KPNA3 (human homolog of yeast KAP122, one of the strongest upregulation suppressors of (Pro-Arg) 50 toxicity). We used a lentivirus to infect rodent primary cortical neurons with a construct expressing (Pro-Arg) 50 . This was highly toxic, consistent with previous reports (Fig. 1h) . Co-infection with a lentivirus encoding KPNA3 more than doubled the survival of neurons expressing Human iNs from three healthy control subjects and two C9orf72-ALS patients were compared. Mean ± s.e.m., n = 13 healthy controls, n = 8 C9orf72-ALS. **P < 0.01, unpaired t-test. 
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Ran GDP/GTP exchange factor: SRM1 50 , in comparison to co-infection with a GFP-expressing virus (Fig. 1h) . KPNA3 upregulation did not affect the levels or distribution of (Pro-Arg) 50 ( Supplementary  Fig. 3 ) and did not completely rescue toxicity, consistent with probable contributions to toxicity from other modifiers (for example, additional karyopherins or even other pathways).
Beyond karyopherins, we identified other genetic modifiers that underscore nuclear import and export as a critical target of DPRs (Fig. 1g) . These include NDC1, a key component of the nuclear pore complex, and regulators of the Ran-GTPase cycle, which generates the energy to power nuclear import. Upregulation of SRM1, the yeast homolog of the human Ran guanine-nucleotide exchange factor RCC1, enhanced (Pro-Arg) 50 toxicity. Targeting this regulator may permit modulation of Ran-GTP levels to overcome nuclear transport defects caused by C9orf72 DPRs.
Our genetic results are consistent with arginine-rich C9orf72 DPRs disrupting nucleocytoplasmic transport. As a first step to validate this result in human disease, we next analyzed neurons derived from three control subjects and two C9orf72 mutation carriers. We directly converted fibroblasts into induced neurons (iNs) using the proneural transcription factors NGN2 and ASCL1, through methods similar to those previously described 18 . We examined the integrity of nucleocytoplasmic transport in human iNs by quantifying the nuclear/cytoplasmic localization of RCC1, a Ran guanine nucleotide exchange factor. In control iNs, RCC1 was strongly localized to the nucleus. However, 70-80% of the C9orf72-carrier iNs had either no or only very weak nuclear RCC1 signal compared to their cytoplasmic staining (Fig. 1i,j) . We also examined the localization of five other proteins implicated in nucleocytoplasmic transport-LMNB1, TPNO3, KPNA3, RANGAP1 and XPO5-but did not observe major differences between C9orf72-carrier iNs and controls ( Supplementary  Fig. 4) . Future studies will be required to further define the effect of C9orf72 mutations on nucleocytoplasmic transport in human cells and in animal models 19 .
In addition to the nuclear import and export proteins, we identified several genes involved in ribosomal RNA processing as potent modifiers of Pro-Arg toxicity. Dramatic disruptions in rRNA biogenesis by C9orf72 DPRs have previously been reported 7, 20 , but whether these defects were cause or consequence of DPR toxicity was unclear. Our data demonstrating potent rescue of DPR toxicity by genetic manipulation of the S, suppressor of (Pro-Arg) 50 toxicity (S1, moderate; S2, strong); E, enhancer of (Pro-Arg) 50 toxicity (E1, moderate; E2, strong; E3, very strong).
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rRNA processing machinery indicate that rRNA processing pathway alterations are a critical component of DPR toxicity and, crucially, can be overcome by restoring rRNA processing machinery function. Intriguingly, we identified NSR1 as a strong modifier of (Pro-Arg) 50 toxicity: deletion suppressed toxicity ( Table 2 ) and upregulation enhanced toxicity ( Table 1) . NSR1 encodes the yeast homolog of human nucleolin, a nucleolar protein whose disruption has been recently implicated in c9FTD/ALS pathogenesis 20 .
Because the arginine-rich DPRs Gly-Arg and Pro-Arg may promote toxicity through a common pathway, we next examined the effects of some of the strongest (Pro-Arg) 50 toxicity modifiers in yeast expressing Gly-Arg. We tested 12 out of 16 deletion suppressors from the (Pro-Arg) 50 screen, and 11 out of 12 of these suppressed (Gly-Arg) 100 toxicity ( Table 2) . (Gly-Arg) 100 toxicity in the W303 strain background was not sufficient to test the suppressors and enhancers from the overexpression screen (data not shown). Future comprehensive screens for modifiers of (Gly-Arg) 100 toxicity (as well as the other DPRs, such as Gly-Ala, Gly-Pro and Pro-Ala) will hopefully provide even further insight into shared and distinct mechanisms of DPR toxicity.
Using two unbiased genetic screens in yeast, we identified a network of potent modifiers of C9orf72 DPR toxicity. These modifiers, especially the gene deletions that suppress toxicity, could point to a druggable target that antagonizes DPR toxicity in c9FTD/ALS. Beyond potential drug targets, the modifiers suggest hypotheses about mechanisms of DPR toxicity (for example, impairments in nucleocytoplasmic transport, both import and export (Fig. 1g) ).
MeThODS
Methods and any associated references are available in the online version of the paper. 
ONLINe MeThODS
Yeast strains, media and plasmids. Yeast cells were grown in rich medium (YPD) or in synthetic media lacking uracil and containing 2% glucose (SD-Ura), raffinose (Sraf-Ura) or galactose (Sgal-Ura). To generate C9orf72 dipeptide expression constructs (Pro-Arg) 50 , (Pro-Ala) 50 , (Gly-Ala) 50 and (Gly-Arg) 50 , we used codon-optimized DPR sequences using Mfold software to minimize the formation of stable RNA secondary structures. ATG-DPR-FLAG constructs were synthesized by Genscript (Piscataway, USA) and were flanked by attB sites. pDONR-(Gly-Arg) 100 was synthesized by GeneArt (Life Technologies) Constructs were further subcloned into a pDONR221 plasmid and subsequently used in Gateway LR reactions with pAG416GAL-ccdB or pAG303GAL-ccdB to produce yeast expression vectors. All constructs were verified by DNA sequencing. pAG416GAL-DPR constructs were transformed into the Y7092 strain. pAG303GAL-DPR constructs were transformed into the W303 strain. Strains were manipulated and media prepared using standard techniques.
Yeast transformation and spotting assays. Yeast procedures were performed according to standard protocols. We used the PEG/lithium acetate method to transform yeast with plasmid DNA. For spotting assays, yeast cells were grown overnight at 30 °C in liquid Sraf-Ura medium until they reached log or mid-log phase. Cultures were then normalized for OD 600 , serially diluted and spotted with a Frogger (V&P Scientific) onto synthetic solid media lacking uracil and containing glucose (SD-Ura) or galactose (Sgal-Ura), and grown at 30 °C for 2-3 d.
Yeast genetic screens. The yeast FLEXGene collection was used to perform the genome-wide plasmid overexpression screen 21 . Plasmid DNA from the expression clones were isolated using the Plasmid Plus 96 miniprep kit (Qiagen). DNA was dried in individual wells of 96-well microtiter plates and transformed into a strain expressing (Pro-Arg) 50 integrated at the HIS3 locus. A standard lithium acetate transformation protocol was modified for automation and used by employing a BIOROBOT Rapidplate 96-well pipettor (Qiagen). The transformants were grown in synthetic deficient medium lacking uracil (SD-Ura) with glucose overnight. The overnight cultures were inoculated into fresh SD-Ura medium with raffinose and allowed to reach stationary phase. The cells were spotted onto SD-Ura + glucose and SD-Ura + galactose agar plates. Suppressors of (Pro-Arg) 50 -induced toxicity were identified on galactose plates after 2-3 d of growth at 30 °C. We repeated the screen two independent times and candidate modifier genes were retested at least three times to confirm their authenticity.
To exclude false-positive enhancer genes caused by a general inhibition of growth unrelated to (Pro-Arg) 50 expression, these genes were transformed into wild-type yeast cells and their effect on growth determined. We used synthetic genetic array (SGA) analysis to identify nonessential yeast deletions that modify C9orf72 dipeptide toxicity, performing this screen essentially as described in ref. 22 with some modifications using a Singer RoToR HAD (Singer Instruments). We mated MATα strain expressing (Pro-Arg) 50 under the galactose promoter to the yeast haploid deletion collection of nonessential genes (MATa, each gene deleted with KanMX cassette conferring resistance to G418). Following diploid selection and sporulation, we selected haploids carrying both deletion and (Pro-Arg) 50 expression cassette. Colony sizes were measured using the HT Colony Grid Analyzer 23 . The raw values were normalized by dividing them by the median colony size of the plate. We performed the entire screen two independent times and confirmed each of the candidate modifier genes at least two times to confirm their authenticity.
We tested effects of the deletions on (Pro-Arg) 50 expression levels. Some modifiers (for example, dhh1∆, gtr1∆, sgo1∆, ski8∆, stp1∆ and uaf30∆) lowered levels of (Pro-Arg) 50 (Supplementary Fig. 1c) . Deletion of these six genes did not have any effect on levels of YFP expressed under the same promoter ( Supplementary  Fig. 1d) , and five of them had no effect on toxicity of α-synuclein (α-syn) or TDP-43 (Supplementary Fig. 2a,b and data not shown). One (Pro-Arg) 50 toxicity suppressor, ski8∆, also suppressed TDP-43 toxicity (Supplementary Fig. 2a ) but had no effect on α-syn toxicity (Supplementary Fig. 2b ). These modifiers represent a noteworthy class that might regulate expression levels or stability of this DPR specifically. Regulating levels of toxic neurodegenerative disease proteins is emerging as a important way to combat their toxicity. Finally, one modifier, ubr2, suppressed toxicity of all three toxic proteins ((Pro-Arg) 50 , TDP-43 and α-syn).
This gene encodes an E3 ubiquitin ligase, perhaps pointing to a common way to mitigate toxicity from diverse aggregation-prone disease proteins.
Immunocytochemistry in yeast cells. For immunocytochemistry, yeast was induced in 2% galactose for 5 h and then fixed with 4% paraformaldehyde for 1 h at room temperature. Cells were collected by centrifugation, washed twice with PBS and resuspended in 1 ml of solution A (0.5 mM MgCl 2 , 1.2 M sorbitol, 40 mM K 3 PO 4 , pH 6.5). To generate spheroplasts, we added 10 µl of β-mercaptoethanol and 25 µl of 10 mg/ml lyticase for 15 min at 37 °C. Spheroplasted cells were collected by centrifugation, washed once with 1 ml of PBS and once with 1 ml of solution A, and resuspended in 250 µl of PBS+BSA (PBS with 1 mg/ml BSA). 150 µl of cell suspension was incubated on Superfrost Plus slides (Fisher) for 5 min and blocked with 50 µl of PBS+BSA for 30 min at room temperature. Cells were then incubated with anti-FLAG antibody (1:100, Sigma F1804), washed three times with PBS, incubated with anti-mouse secondary antibody (1:800, Invitrogen 21203) and washed three times with PBS. Samples were mounted using ProLong Gold with DAPI (Life Technologies).
Functional enrichment analysis. Functional enrichment analysis was performed with the Functional Annotation Chart tool of DAVID v. 6.7 (ref. 24) using the S. cerevisiae genome as background 24 .
mouse primary neuron culture. All mouse experiments were performed in compliance with Stanford Administrative Panel on Laboratory Animal Care guidelines and regulations. E17 mouse cortical neurons were isolated using the Papain Dissociation System (Worthington Biochemicals, LK003150), plated on poly-l-lysine coated plates and grown in Neurobasal medium supplemented with B-27 (Invitrogen) and glutamine. At DIV4 neurons were transduced with lentiviruses encoding GFP, (Pro-Arg) 50 or KPNA3, under conditions that conferred transduction efficiency of ≥95%. Five days after infection neuronal survival was assessed by NeuN (1:1,000, Millipore MAB377) counting. The experiment assessing the effects of KPNA3 upregulation on (Pro-Arg) 50 toxicity in mouse neurons was repeated three independent times. In each experiment, neuronal survival was assessed in a minimum of six separate wells for each condition. All images were obtained and neuronal numbers assessed in a blinded fashion.
